These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 2442991

  • 1. Beta blockers in combination with class I antiarrhythmic agents.
    Deedwania PC, Olukotun AY, Kupersmith J, Jenkins P, Golden P.
    Am J Cardiol; 1987 Aug 31; 60(6):21D-26D. PubMed ID: 2442991
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of nadolol alone or in combination with a type IA antiarrhythmic drug in sustained ventricular tachycardia: a prospective study.
    Munsif AN, Saksena S.
    Pacing Clin Electrophysiol; 1989 Nov 31; 12(11):1816-26. PubMed ID: 2478982
    [Abstract] [Full Text] [Related]

  • 3. Beta-adrenergic blockade by nadolol in control of ventricular tachyarrhythmias.
    Nademanee K, Schleman MM, Singh BN, Morganroth J, Reid PR, Stritar JA.
    Am Heart J; 1984 Oct 31; 108(4 Pt 2):1109-15. PubMed ID: 6207720
    [Abstract] [Full Text] [Related]

  • 4. Proarrhythmic effects of antiarrhythmic drugs during programmed ventricular stimulation in patients without ventricular tachycardia.
    Au PK, Bhandari AK, Bream R, Schreck D, Siddiqi R, Rahimtoola SH.
    J Am Coll Cardiol; 1987 Feb 31; 9(2):389-97. PubMed ID: 2433319
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Combination of procainamide and quinidine for better tolerance and additive effects for ventricular arrhythmias.
    Kim SG, Seiden SW, Matos JA, Waspe LE, Fisher JD.
    Am J Cardiol; 1985 Jul 01; 56(1):84-8. PubMed ID: 4014046
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias.
    Coumel P, Leclercq JF, Assayag P.
    Am J Cardiol; 1984 Nov 14; 54(9):60D-66D. PubMed ID: 6208770
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery disease.
    Greenspan AM, Spielman SR, Webb CR, Sokoloff NM, Rae AP, Horowitz LN.
    Am J Cardiol; 1985 Aug 01; 56(4):277-84. PubMed ID: 4025166
    [Abstract] [Full Text] [Related]

  • 16. The effectiveness of antiarrhythmic agents on early-cycle premature ventricular complexes.
    Krone RJ, Miller JP, Kleiger RE, Clark KW, Oliver GC.
    Circulation; 1981 Mar 01; 63(3):664-9. PubMed ID: 7006853
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.